INTRODUCTION
Recently, there is a trend towards combined therapy for the treatment of various diseases and disorders that require long-term therapy such as arthritis and osteoarthritis. The main advantage of combined therapy is to counteract the destructive effects of one drug. [1] . Chemically Famotidine is 3-([2-(diaminomethyleneamino) thiazol-4-yl]methylthio)-N'-sulfamoylpropanimidamide which is H 2 -receptor antagonist used for treating and preventing gastric & duodenal ulcers [2] [3] [4] [5] and flurbiprofen is known as (RS)-2-(2-fluorobiphenyl-4-yl) which is propionic acid [6] . Structure of both drugs are shown in Figure 1 .
Bi-layer tablets are drug delivery system in which two drugs are combined in a single unit. Simultaneous method validation is used to affirm that analytical method for specific test is suitable or not. Results of method validation can be confirmed for their quality, reliability and consistency of analytical results. Various methods have been discussed in the literature for determination of Famotidine and Flurbiprofen tablets like spectrophotometric analysis [2] , potentiometric [7] , electrochemical, Flow injection analysis (FIA). Among them, High performance liquid chromatography is precise, specific, rapid and simple. There is a need of such HPLC methods for detection of two drugs in a single dosage form.
The object of this study is to formulate the bilayer tablets of Flurbiprofen and Famotidine by establishing new HPL analytical method of both drugs. Famotidine was used as immediate release (IR) and Flurbiprofen hold as sustained release (SR) effect. Validation of the method was carried out by evaluating the accuracy, precision, stability, system suitability and precision of the method.
EXPERIMENTAL Instruments and apparatus
Analytical balance (Electronic Balance Model AED-300), High Performance Liquid Chromatographic system (SYKAM S5111), Prepacked Column RT 250-4.6 Purospher ® STAR RP-18 end capped (5 µm), Rheodyne manual injector fitted with a 20 μl loop syringe (SGE Company, Australia), ultrasonic bath (Shenzhen Co. China) membrane disc filters (Millipore, 0.45 µm pore size, Millipore Corporation, Billerica, USA).
Chemicals
Famotidine and Flurbiprofen both were gifted by Zakfas pharmaceutical (Pvt) Ltd Multan, HPMC (Methocell K4M, Dow Chemical Co., USA), Avicel PH 102 (FMC, Brussels, Belgium), Carboxymethylcellulose (Ac-di-sol®, FMC biopolymer, USA). Potassium dihydrogen phosphate, methanol, phosphoric acid and sodium hydroxide all were purchased from Merck, Darmstadt, Germany and were of analytical grade. Double distilled water was used in whole study.
Compression of bilayer tablets
Single punch machine was used for compression of bilayer tablets in such a way that sustained release layer of Flurbiprofen granules were compressed initially and then immediate layer of Famotidine was compressed by direct compression. Oblong faced punch was used for compression of 20 mg Famotidine and 238 mg Flurbiprofen for obtaining the weight ranges of 827 to 1011 mg in each tablet. Similar composition of placebo (without active pharmaceutical ingredients) formulations were also compressed by same single punch machine for comparative study.
Preparation of buffer, mobile phase and stock solutions
Phosphate buffer solution of pH 3.7 was mixed with acetonitrile with the ratio 1:1. A stock solution of different strengths, i.e., 1 mg/ml of Flurbiprofen and Famotidine was prepared which was further diluted in 100, 50, 25 and 10 ppm were prepared in the mobile phase.
Method validation
The validation parameters determined were linearity, selectivity, accuracy, precision, system suitability, solution stability, Limit of detection (LOD), and Limit of quantification (LOQ) as per the guidelines of ICH Q2B [8] .
Specificity
The specificity of the method was used to differentiate between the analyst and the components in the sample. Interference between the solvents and formulation chromatograms of six replicate injections of placebo with standard Flurbiprofen and Famotidine were evaluated for specificity [9] . 
Linearity (calibration curve)
To calculate the linear relationship between the range of concentration of the API and the detector response linearity curve was used. Linearity was assessed by forming the dilution in such a way that 50 ppm was kept as a central point, two high and two lower concentrations were prepared from stock solution and the linearity curve was developed [9] .
Reproducibility and accuracy
Spike Placebo method was used for calculating the accuracy [10] . Sample solutions with 10, 25, 50, 75 and 10 ppm concentrations were prepared and spiked with placebo solution.
Inter-and intra-day precision
Analysis of Inter-day precision was carried out by selecting five concentrations for three consecutive days, whereas intraday precision was carried out by using five different concentrations i.e., 10, 25, 50, 75 and 100 ppm [11] .
System suitability test (SST)
The system suitability was assessed with the initial mobile phase composition, followed by 10 injections of the same standard. The purpose of injecting 10 consecutive injections was to evaluate the system suitability on each day of method validation. Parameters like capacity factor > 2, resolution > 3 and asymmetric tailing factor < 2, theoretical plates of column > 3000 were calculated. All parameters were recorded by Clarity Lite Chromatography Station for windows [12] .
Theoretical plates
Following equations were used to evaluate the theoretical plates of the reports [15, 16] . h=L/n ……………………………………… (1) n=16(t/Wb)2 ...……………………….......... (2) where h = theoretical plate values. Wb is the peak width of base, t is Retention time and L is the length of column.
Tailing factor
T=w/2f………………………………………… (3) where w is the width at 5 % of peak height and f is the distance between the maximum and leading edge of the peak.
Solution stability
For quantification analysis the stability of solution is essential. Shelf life was determined by keeping the sample for 12 h, and it was estimated at -15 to -20 °C for 7 days. All the experiments were repeated six times.
Determination of quantitation limits (sensitivity)
Limit of detection LOD is the minute amount of analyte in a given method that may be detected, but not necessarily quantitated. To determine LOD of this method, 0.01 ppm of standard solution was injected five times and was set as LOD and the concentration was analyzed by using the formula LOD = 3.3 SD/slope and subjected to regression analysis, SD and % CV determination.
LOQ is the lowest concentration of the analyte that can be constituted having an acceptable degree of certainty [9] . Since the standard curve was examined from 10 to 100 ppm. Peak (response) was clearly identifiable, discrete and reproducible as requirement of Food and Drug Administration (FDA) guidance.
Statistical analysis
Statistical analysis of the both linearity curve of famotidine and flurbiprofen was applied for the calculation of coefficient of correlation values, slope and y axis intercept. Microsoft Excel 2007 was used for the evaluation of analysis of variance (ANOVA). Relative standard deviation (%RSD) was calculated using Eq 4.
RESULTS
The method showed good sensitivity, selectivity, baseline resolved peaks and excellent resolution as required in method validation guidelines by the International Conference on the Harmonization of Pharmaceuticals for Human Use (ICH) Q2B [8] . Accuracy, precision, linearity, specificity, solution stability, system suitability, LOD and LOQ were successfully calculated. The results revealed that recovery was 99.611 % after 12 h and 99.760 % after 7 days for famotidine and 99.60 % for 24 h and 99.845 % after 7 days for flurbiprofen. Temperature effect on the Flurbiprofen and Famotidine at ambient and freeze form are shown in table 1. Ambient temperature 15-20 °Ċ were applied for 7 days in 50 ppm solution of flurbiprofen and famotidine. Similarly, relative standard deviation (%RSD) of area for both drugs was 0.175 and 1.327 which is < 2. Theoretical plates were 4156.6 for flurbiprofen and 6532.2 for famotidine. RSD of tailing factor was 0.986 and 0.154 % for flurbiprofen and famotidine, respectively, and was within limit of < 2. LOD was 10 ppm while LOQ was 50 ppm. No detection of interfering recipients was detected between sample, standard and placebo as shown in Figure 2 . For the evaluation of resolution and reproducibility of the method, the results of the system suitability test are shown in Table 2 while accuracy results are shown in table 3. By injecting replicate injections of five selected concentrations 100,75,50,25 and 10 ppm gave the evidence of accuracy Table 3 showed the percent recovery for each concentration of Famotidine and Flurbiprofen respectively. Statistical data results such as coefficient of correlation was found to be 0.999 in Famotidine while it was 0.999 in Flurbiprofen which showed linear regression as shown in Table 2 Table 4 . Table 2 . All results were within limits of ICH guideline. Shah et al reported same results after studying the combined formulation [15] . Similarly succinate and amlodipine was studied in bilayerd tablets formulations and reported the system suitability with its theoretical plates values [16] .
By injecting replicate injections of five selected concentrations 100,75,50,25 and 10 ppm gave the evidence of accuracy Table 3 showed the percent recovery for each concentration of Famotidine and Flurbiprofen respectively. Similar findings were reported for determination of Flurbiprofen by HPLC and reported the accuracy level of five different concentrations [17] . Ampicillin and cloxacillin were in the combined formulation was studied and reported accurate and precise method for both drugs [18] . Table 4 . Similar finding were also reported by after explaining the HPLC method validation of Nimesulide tablets [9] . Atorvastatin and amlodipine were studied in combined formulation and reported the isocratic mobile phase of both drug after using the range of 1-90 mg/ml.
CONCLUSION
The HPLC method used shows good separation, linearity, precision, accuracy and selectivity for the simultaneous analysis of the two drugs, and it should also be convenient, simple and reliable to use, not only in vitro analysis, but also in vivo studies.
